International Assets Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18K Buy
60
+32
+114% +$635 ﹤0.01% 2187
2026
Q1
$546 Hold
28
﹤0.01% 2122
2025
Q4
$530 Buy
+28
New +$519 ﹤0.01% 2097
2024
Q4
Sell
-6,104
Closed -$328 1708
2024
Q3
$328 Buy
6,104
+5,776
+1,761% +$97.4K ﹤0.01% 1446
2024
Q2
$5.05K Buy
+328
New +$4.69K ﹤0.01% 1847
2023
Q2
Sell
-552
Closed -$6.35K 869
2023
Q1
$6.35K Buy
+552
New +$6.83K ﹤0.01% 885
2021
Q2
Sell
-1,104
Closed -$20K 1630
2021
Q1
$20K Buy
1,104
+552
+100% +$9.71K ﹤0.01% 1305
2020
Q4
$10K Buy
+552
New +$8.81K ﹤0.01% 1437

Other funds holding SBRA

International Assets Investment Management's SBRA Position: Q2 2026 in Review

International Assets Investment Management increased its Sabra Healthcare REIT (SBRA) stake by 114% in Q2 2026, buying an estimated $635 and bringing the position to 60 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2187.

International Assets Investment Management first reported a position in SBRA in Q4 2020 and has held it in 8 quarters since. The position peaked at $20K in Q1 2021. 280 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • International Assets Investment Management held 60 shares of Sabra Healthcare REIT worth $1.18K as of Q2 2026.
  • International Assets Investment Management bought 32 Sabra Healthcare REIT shares in Q2 2026, an estimated $635.
  • Sabra Healthcare REIT made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2187 holding.
  • International Assets Investment Management first reported a position in Sabra Healthcare REIT in Q4 2020 and has held it in 8 quarters since.
  • International Assets Investment Management's Sabra Healthcare REIT position peaked at $20K in Q1 2021.
  • 280 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.